As of Feb 17
| +0.06 / +0.15%|
The 11 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 44.00, with a high estimate of 60.00 and a low estimate of 25.00. The median estimate represents a +12.02% increase from the last price of 39.28.
The current consensus among 11 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.